Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Data from secondary source

Data source

Reference
Reference Type:
secondary source
Title:
Acute oral toxicity study in mouse for CAS no: 1313-96-8
Author:
U.S .National library of medicine
Year:
2017
Bibliographic source:
ChemID plus A TOXNET DATABASE.2017

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
other: As mentioned below
Principles of method if other than guideline:
Acute oral toxicity study of Niobium pentoxide was performed in mouse
GLP compliance:
not specified
Test type:
other: not specified
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Niobium pentoxide
Cas Number:
1313-96-8
Molecular formula:
Nb2O5
IUPAC Name:
Niobium pentoxide
Details on test material:
- Name of test material (as cited in study report):Niobium pentoxide
- Molecular formula :Nb2O5
- Molecular weight :265.80g/mole
- Substance type:Inorganic
- Physical state:No data available
- Purity:No data available
- Impurities (identity and concentrations):No data available
Specific details on test material used for the study:
- Name of test material (as cited in study report):Niobium pentoxide
- Molecular formula :Nb2O5
- Molecular weight :265.80g/mole
- Substance type:Inorganic
- Physical state:No data available
- Purity:No data available
- Impurities (identity and concentrations):No data available

Test animals

Species:
mouse
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
No data available

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified
Details on oral exposure:
No data available
Doses:
4000mg/kg bw
No. of animals per sex per dose:
No data available
Control animals:
not specified
Details on study design:
No data available
Statistics:
No data available

Results and discussion

Preliminary study:
No data available
Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 4 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: No mortality was observed
Mortality:
No mortality was observed
Clinical signs:
other: Behavioural, muscle contraction or spasticity liver (hepatitis i .e hepatocellular necrosis), in lungs, thorax, or respiration: acute pulmonary edema was observed in treated mouse.
Gross pathology:
No data available
Other findings:
No data available

Applicant's summary and conclusion

Interpretation of results:
other: Not classified
Conclusions:
LD50 was considered to be >4000mg/kg body weight. When mouse was treated with Niobium pentoxide (1313-96-8) orally.
Executive summary:

Acute oral toxicity study was done in mouse usingNiobium pentoxide(1313-96-8).No mortality was observed at dose 4000mg/kg bw. Clinical signs like Behavioral,muscle contraction or spasticity liver (hepatitis i .e hepatocellular necrosis), in lungs, thorax, or respiration: acute pulmonary edema was observed in treated mouse. Hence, LD50was considered to be>4000mg/kgbody weight. When mouse was treated with Niobium pentoxide(1313-96-8)orally